- Home
- IDYA vs NWL Comparison
IDYA vs NWL Comparison
Compare IDYA & NWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- NWL
- Stock Information
- Founded
- IDYA 2015
- NWL 1903
- Country
- IDYA United States
- NWL United States
- Employees
- IDYA N/A
- NWL N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- NWL Plastic Products
- Sector
- IDYA Health Care
- NWL Industrials
- Exchange
- IDYA Nasdaq
- NWL Nasdaq
- Market Cap
- IDYA 2.2B
- NWL 2.4B
- IPO Year
- IDYA 2019
- NWL N/A
- Fundamental
- Price
- IDYA $24.27
- NWL $5.09
- Analyst Decision
- IDYA Strong Buy
- NWL Buy
- Analyst Count
- IDYA 13
- NWL 8
- Target Price
- IDYA $51.36
- NWL $7.31
- AVG Volume (30 Days)
- IDYA 1.1M
- NWL 8.1M
- Earning Date
- IDYA 08-05-2025
- NWL 08-01-2025
- Dividend Yield
- IDYA N/A
- NWL 5.40%
- EPS Growth
- IDYA N/A
- NWL N/A
- EPS
- IDYA N/A
- NWL N/A
- Revenue
- IDYA $7,000,000.00
- NWL $7,397,000,000.00
- Revenue This Year
- IDYA $101.44
- NWL N/A
- Revenue Next Year
- IDYA $263.37
- NWL $1.53
- P/E Ratio
- IDYA N/A
- NWL N/A
- Revenue Growth
- IDYA N/A
- NWL N/A
- 52 Week Low
- IDYA $13.45
- NWL $4.22
- 52 Week High
- IDYA $40.74
- NWL $11.78
- Technical
- Relative Strength Index (RSI)
- IDYA 52.57
- NWL 44.76
- Support Level
- IDYA $22.09
- NWL $4.79
- Resistance Level
- IDYA $24.75
- NWL $5.23
- Average True Range (ATR)
- IDYA 1.25
- NWL 0.27
- MACD
- IDYA -0.13
- NWL -0.04
- Stochastic Oscillator
- IDYA 40.05
- NWL 32.08
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About NWL Newell Brands Inc.
Newell Brands Inc is an American consumer goods company with a strong portfolio of well-known brands, including Rubbermaid, Sharpie, Graco, Coleman, Rubbermaid Commercial Products, Yankee Candle, Paper Mate, FoodSaver, Dymo, EXPO, Elmer's, Oster, NUK, Spontex and Campingaz. The group is focused on delighting consumers by lighting up everyday moments. Its segments are Home and Commercial Solutions, Learning and Development, and Outdoor and Recreation. The group geographic areas are the United States, Canada, Europe, the Middle East and Africa, Asia Pacific, and Latin America.